Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Sep-24 3:28 PM View:  | Perrigo Co Plc (PRGO) | 13-Sep-24 | Sale | 8,954 | $27.30 | $244,444.00 | (60%) 14.96K to 6.01K | |
| 16-May-24 7:27 PM View: | Perrigo Co Plc (PRGO) | 15-May-24 | Payment of Exercise | 4,207 | $30.22 | $127,136.00 | (22%) 19.17K to 14.96K | |
| 16-May-24 7:27 PM View: | Perrigo Co Plc (PRGO) | 15-May-24 | Option Exercise | 8,764 | $30.22 | $264,848.00 | 84% 10.41K to 19.17K | |
| 19-May-23 2:39 PM View: | Perrigo Co Plc (PRGO) | 17-May-23 | Payment of Exercise | 3,734 | $32.86 | $122,699.00 | (26%) 14.14K to 10.41K | |
| 19-May-23 2:39 PM View: | Perrigo Co Plc (PRGO) | 17-May-23 | Option Exercise | 7,778 | $32.86 | $255,585.00 | 122% 6.36K to 14.14K | |
| 19-May-22 1:54 PM View: | Perrigo Co Plc (PRGO) | 17-May-22 | Payment of Exercise | 3,168 | $38.57 | $122,190.00 | (33%) 9.53K to 6.36K | (8%) |
| 19-May-22 1:54 PM View: | Perrigo Co Plc (PRGO) | 17-May-22 | Option Exercise | 6,599 | $38.57 | $254,523.00 | 225% 2.93K to 9.53K | 8% |
| 16-Aug-21 12:02 PM View: | Perrigo Co Plc (PRGO) | 12-Aug-21 | Payment of Exercise | 2,706 | $41.28 | $111,704.00 | (48%) 5.64K to 2.93K | 9% |
| 16-Aug-21 12:02 PM View: | Perrigo Co Plc (PRGO) | 12-Aug-21 | Option Exercise | 5,637 | $41.28 | $232,695.00 | 100% 0 to 5.64K | (9%) |
| 11-Jun-19 4:23 PM View: | Bemis Co. Inc. (BMS) | 11-Jun-19 | Disposition | 5,851 | -- | -- | (100%) 5.85K to 0 | |
| 04-May-18 1:27 PM View: | Bemis Co. Inc. (BMS) | 03-May-18 | Grant | 3,095 | -- | -- | 120% 2.58K to 5.68K | |
| 04-Aug-17 5:31 PM View: | Bemis Co. Inc. (BMS) | 02-Aug-17 | Grant | 2,530 | -- | -- | 100% 0 to 2.53K | |
| 27-May-14 5:02 PM View: | Abbott Laboratories (ABT) | 23-May-14 | Payment of Exercise | 4,198 | $39.65 | $166,451.00 | (9%) 47.52K to 43.33K | (180%) |
| 13-Mar-15 5:29 PM View: | Abbott Laboratories (ABT) | 15-Apr-14 | Market Sale | 10 | $37.58 | $375.82 | (< 1%) 43.48K to 43.47K | (196%) |
| 13-Mar-15 5:29 PM View: | Abbott Laboratories (ABT) | 14-Mar-14 | Market Purchase | 52 | $39.11 | $2,033.51 | < 1% 43.43K to 43.48K | 186% |
| 04-Mar-14 5:04 PM View: | Abbott Laboratories (ABT) | 03-Mar-14 | Market Sale | 6,639 | $39.01 | $258,964.00 | (12%) 54.16K to 47.52K | (187%) |
| 04-Mar-14 5:04 PM View: | Abbott Laboratories (ABT) | 28-Feb-14 | Payment of Exercise | 4,043 | $39.79 | $160,871.00 | (7%) 58.21K to 54.16K | (181%) |
| 25-Feb-14 5:04 PM View: | Abbott Laboratories (ABT) | 21-Feb-14 | Grant | 14,220 | -- | -- | 32% 43.99K to 58.21K | |
| 13-Mar-15 5:29 PM View: | Abbott Laboratories (ABT) | 03-Feb-14 | Market Sale | 1 | $35.93 | $35.93 | (< 1%) 43.43K to 43.43K | (211%) |
| 13-Mar-15 5:29 PM View: | Abbott Laboratories (ABT) | 03-Dec-13 | Market Purchase | 4 | $37.50 | $150.00 | < 1% 43.43K to 43.43K | 200% |
| 13-Mar-15 5:29 PM View: | Abbott Laboratories (ABT) | 31-Oct-13 | Market Purchase | 102 | $36.71 | $3,744.22 | < 1% 43.33K to 43.43K | 206% |
| 28-May-13 5:05 PM View: | Abbott Laboratories (ABT) | 23-May-13 | Payment of Exercise | 2,982 | $37.72 | $112,481.00 | (6%) 46.97K to 43.99K | (201%) |